Treatment optimization of angiotensin converting enzyme inhibitors and associated factors in Ayder Comprehensive Specialized Hospital: a cross-sectional study

BACKGROUND: Angiotensin-converting enzyme inhibitors have morbidity and mortality benefits in heart failure. Failure to optimize treatment using these medications increases hospitalizations, worsens signs and symptoms of heart failure, and reduces the overall treatment outcome. Therefore, the main p...

Descripción completa

Detalles Bibliográficos
Autores principales: Atey, Tesfay Mehari, Teklay, Tsegay, Asgedom, Solomon Weldegebreal, Mezgebe, Haftay Berhane, Teklay, Gebrehiwot, Kahssay, Molla
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2018
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5875017/
https://www.ncbi.nlm.nih.gov/pubmed/29592815
http://dx.doi.org/10.1186/s13104-017-2820-5

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5875017/
https://www.ncbi.nlm.nih.gov/pubmed/29592815
http://dx.doi.org/10.1186/s13104-017-2820-5

Ejemplares similares